Katona, Bryson W <br/><br/>
Combined Menin and EGFR Inhibitors Synergize to Suppress Colorectal Cancer via EGFR-Independent and Calcium-Mediated Repression of SKP2 Transcription.  [electronic resource] 

 -  Cancer research  05 2019 
 - 2195-2207 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-18-2133  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis<br/>Biomarkers, Tumor--genetics<br/>Calcium--metabolism<br/>Cell Proliferation<br/>Colorectal Neoplasms--drug therapy<br/>Drug Synergism<br/>Drug Therapy, Combination<br/>Enzyme Inhibitors--pharmacology<br/>ErbB Receptors--antagonists & inhibitors<br/>Female<br/>Gefitinib--pharmacology<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Inositol 1,4,5-Trisphosphate Receptors--genetics<br/>Mice<br/>Mice, Nude<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins--antagonists & inhibitors<br/>S-Phase Kinase-Associated Proteins--antagonists & inhibitors<br/>Thapsigargin--pharmacology<br/>Tumor Cells, Cultured<br/>Xenograft Model Antitumor Assays